ZANGHI', AURORA
 Distribuzione geografica
Continente #
NA - Nord America 372
EU - Europa 212
AF - Africa 64
AS - Asia 60
SA - Sud America 2
Totale 710
Nazione #
US - Stati Uniti d'America 367
IE - Irlanda 74
IT - Italia 58
CN - Cina 44
CI - Costa d'Avorio 40
SN - Senegal 24
DE - Germania 23
RU - Federazione Russa 19
UA - Ucraina 13
VN - Vietnam 10
CA - Canada 5
GB - Regno Unito 5
NL - Olanda 4
FR - Francia 3
IN - India 3
HR - Croazia 2
SE - Svezia 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
EC - Ecuador 1
FI - Finlandia 1
HK - Hong Kong 1
HU - Ungheria 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
PL - Polonia 1
TR - Turchia 1
Totale 710
Città #
Chandler 133
Dublin 74
Abidjan 40
Houston 31
Catania 24
Dakar 24
Ashburn 20
Andover 19
Bremen 19
Cambridge 19
Lawrence 19
Des Moines 13
Jacksonville 9
Nanjing 7
Beijing 6
Boardman 6
Wilmington 6
Dong Ket 5
Hanoi 5
Nanchang 4
Padova 4
Den Haag 3
Hebei 3
Saint Petersburg 3
San Francisco 3
Toronto 3
Boydton 2
Kunming 2
Lanuvio 2
London 2
Moscow 2
New York 2
Ottawa 2
Tianjin 2
Zagreb 2
Acireale 1
Amsterdam 1
Ann Arbor 1
Belpasso 1
Brussels 1
Budapest 1
Campinas 1
Central 1
Changsha 1
Fiumicino 1
Foggia 1
Frankfurt Am Main 1
Guangzhou 1
Helsinki 1
Jiaxing 1
Livorno 1
Luxembourg 1
Mascalucia 1
New Delhi 1
Palermo 1
Providence 1
Pune 1
Quito 1
Rome 1
San Mateo 1
Sant'Ilario d'Enza 1
Scaletta Zanclea 1
Shenyang 1
Sofia 1
Vilnius 1
Washington 1
Zogno 1
Totale 552
Nome #
Management of dysphagia in multiple sclerosis: current best practice 78
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 55
Can new chemical therapies improve the management of multiple sclerosis in children? 51
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 51
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 46
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 44
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 44
An update on the safety of treating relapsing-remitting multiple sclerosis 43
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 40
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in Relapsing-Remitting Multiple Sclerosis: an Italian real-word multicenter experience 40
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 37
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis 33
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 33
Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis Patients 30
Pharmacoeconomics of synthetic therapies for multiple sclerosis 29
Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: Present and future perspectives 28
Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment 27
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 27
Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experience 23
Totale 759
Categoria #
all - tutte 2.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201921 0 0 0 0 0 0 0 0 6 2 9 4
2019/202083 32 4 16 4 4 3 2 2 4 1 4 7
2020/202152 1 5 2 3 20 1 2 0 3 9 1 5
2021/2022126 3 23 4 2 20 1 19 5 3 0 3 43
2022/2023354 22 20 10 53 32 54 1 66 70 1 14 11
2023/2024102 2 37 8 5 2 27 0 21 0 0 0 0
Totale 759